Sofosbuvir / Velpatasvir
Also known as Epclusa (us), Velpanat (india)
A once-daily tablet that cures most hepatitis C over a 12-week course.
Based on 28 tablets month (of a 12-week course). US $850.00 vs India $9.00 per tablet.
The savings here are large enough that a trip may still come out ahead. Adjust the numbers to your own situation — every value is an editable estimate.
- Medicine savings over 6 months
- $141,288
- Estimated travel cost
- − $2,300
- Net savings after travel
- $138,988
Even after travel, you could come out ahead by about $138,988.
Assumptions: medicine savings = (US − India monthly price) × months. Travel cost = flights + hotel × nights + buffer. Excludes consultation fees, visas, and other costs. For information only — not medical, legal, or travel advice.
Sofosbuvir / Velpatasvir is filled about 44.9K times a year under Medicare Part D. At the prices above, that works out to roughly:
Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.